TickerFacts.

Nephros Inc (NEPH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.29M
Year ended 2025-12-31
$1.77M
Trailing 12 months to 2026-06-30
2011-12-31: -$2.22M2012-12-31: -$3.18M2013-12-31: -$3.09M2014-12-31: -$2.45M2015-12-31: -$3.21M2016-12-31: -$2.64M2017-12-31: -$2.01M2018-12-31: -$2.85M2019-12-31: -$2.97M2020-12-31: -$4.08M2021-12-31: -$3.06M2022-12-31: -$4.12M2023-12-31: -$1.38M2024-12-31: $141.0K2025-12-31: $1.29M$1.29M
2011-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$1.29M+812.1%2026-03-12, From 2025-01-01
2024-12-31$141.0Kn/m2026-03-12, From 2024-01-01
2023-12-31-$1.38Mn/m2025-03-24, From 2023-01-01
2022-12-31-$4.12Mn/m2024-03-15, From 2022-01-01
2021-12-31-$3.06Mn/c2023-03-23, From 2021-01-01
2020-12-31-$4.08Mn/m2022-03-03, From 2020-01-01
2019-12-31-$2.97Mn/m2021-03-01, From 2019-01-01
2018-12-31-$2.85Mn/m2020-02-27, From 2018-01-01
2017-12-31-$2.01Mn/m2019-03-12, From 2017-01-01
2016-12-31-$2.64Mn/m2018-02-26, From 2016-01-01
2015-12-31-$3.21Mn/m2017-03-20, From 2015-01-01
2014-12-31-$2.45Mn/m2016-03-30, From 2014-01-01
2013-12-31-$3.09Mn/m2015-04-15, From 2013-01-01
2012-12-31-$3.18Mn/m2014-03-28, From 2012-01-01
2011-12-31-$2.22Mn/a2013-03-04, From 2011-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Nephros Inc (NEPH)2025-12-31$1.29M+812.1%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$2.32Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$18.59Mn/m
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31-$24.53Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$29.17Mn/m
Sensus Healthcare, Inc. (SRTS)2025-12-31-$9.91Mn/m
Nexgel, Inc. (NXGL)2025-12-31-$2.90Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m

Compare NEPH, SNOA, VVOS, BDMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗